Delírio no doente com cancro avançado
Palavras-chave:
delírio, cancro avançado, diagnóstico, tratamento paliativoResumo
As alterações cognitivas são muito comuns em doentes com cancro. O delírio é uma das
complicações neuropsiquiátricas mais frequentes nos doentes com cancro avançado. O
delírio pode ser reversível, excepto nas últimas 24 a 48 horas de vida. Muitas vezes não
é diagnosticado pelos profissionais de saúde, sobretudo nos idosos. O início agudo de
flutuação da consciência e da diminuição da atenção, alterações do ciclo sono-vigília,
letargia ou agitação e agravamento dos sintomas durante a noite, são elementos muito
importantes para o diagnóstico. O reconhecimento precoce do delírio e o tratamento da
causa subjacente é essencial. AA. faz uma revisão sobre as características clínicas,
etiologia, diagnóstico e tratamento desta situação.
Downloads
Referências
Lipowski ZJ: Delirium (Acute Confusional States). JAMA 1987;258:1789-1792.
Inouye SK: The dilemma of delirium: clinical and research controversies regarding diagnoses and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994;97:278-288.
Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: A Symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med 1999;106:565-573.
Massie MJ, Holland JC, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983; 140: 1048-1050.
Conill C, Verger E, Henriquez I et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997; 14: 328-331.
Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive in patients with terminal cancer. Cancer 1997;79(4):835-842.
Tune L, Carr S, Hoag E et al. Anticholinergic effects of drugs commonly prescribed for the elderly: Potencial means for assessing risk of delirium. Am J Psychiatry 1992, 149(10): 1393-1394.
Caraceni A: Delirium in palliative medicine. European Journal of Palliative Care 1995; 2 (2): 62-67
Breitbart W, Bruera E, Chochinov H et al. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J. Pain Symptom Manag 1995; 10(2): 131-141.
Rummans TA et al. Delirium in Elderly Patients: evaluation and management. Mayo Clin Proc 1995; 70:989-998.
Breitbart W. Psycho-Oncology: Depression, Anxiety, Delirium. Seminars in Oncology 1994; 21(6): 754 -769.
Breitbart W, Passik S. Psychiatric aspects of palliative care. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. New York, NY: Oxford University Press 1998:933-956.
Smith MJ et al. A critique of instruments and methods to detect, diagnose, and rate delirium. Journal of Pain and Symptom Management 1995; 10(1): 35-77.
Inouye SK et al. Clarifying Confusion: The Confusion Assessment Method. Annals of Internal Medicine 1990, 113: 941-948.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4 th edn. Washington, DC: American Psychiatric Association 1994.
Larson EB, Kukull WA, Buchner D et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987; 107: 169-173.
Lawlor PG, Gagnon B, Mancini IL et al. Occurrence, causes and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160(6): 786-794.
Breitbart W et al. Neuropsychiatric disturbance in cancer patients with epidural spinal cord compression receiving high dose corticosteroids: a prospectivecomparison study. Psycho-Oncology 1993; vol. 2: 233-245.
Massie MJ, Holland JC. The cancer patient with pain: psychiatric complications and their management. Med Clin North America 1987; 71 (2): 243-259.
Bruera E, Neumann CM. The uses of psychotropics in symptom management in advanced cancer. Psycho-Oncology 1998; 7: 346-358.
Stedeford A. Confusion. Baillière’s Clin Oncol 1987; 1(2): 373-384
Mercadante M. Opioid rotation for cancer pain. Cancer 1999; 86 (9): 1856-1866.
Bruera E, Franco JJ, Maltoni M et al. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitivemonitoring, hydration, and opioid rotation. J Pain Symptom Manag 1995; 10(4): 287-291.
Noémi D. de Stoutz, Eduardo Bruera, Maria Suarez-Almazor. Opioid Rotation for Toxicity Redution in Terminal Cancer Patients. J. Pain Symptom Manag1995; 10(5): 378-384.
Lichter I, Hunt E. The last 48 hours of life. J Palliative Care 1990; 6(4): 7-15.
Faisinger RL, Moissac D, Mancini I et al. Sedation for delirium and othersymptoms in terminally ill patients in Edmonton. J Palliative Care 2000; 16(2): 5-10.
Reus VI. Olanzapine: a novel atypical neuroleptic agent. The Lancet 1997;349(3): 1264-1265.
Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium.Psychosomatics 1998; 39: 422-430.
Passik SD, Cooper M. Complicated delirium in a cancer patient successfully treated with olanzapine. Journal of Pain and Symptom Manag 1999; 17(3): 219-223
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
